ARDIGHIERI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 1.859
AS - Asia 1.131
EU - Europa 944
SA - Sud America 148
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
AN - Antartide 1
Totale 4.106
Nazione #
US - Stati Uniti d'America 1.805
SG - Singapore 403
CN - Cina 311
IT - Italia 272
DE - Germania 162
BR - Brasile 119
HK - Hong Kong 113
VN - Vietnam 107
FI - Finlandia 87
EE - Estonia 67
FR - Francia 48
GB - Regno Unito 48
UA - Ucraina 46
BD - Bangladesh 45
PL - Polonia 39
TR - Turchia 38
RU - Federazione Russa 36
CA - Canada 34
IE - Irlanda 32
IN - India 31
ID - Indonesia 21
NL - Olanda 20
ES - Italia 17
SE - Svezia 16
AR - Argentina 15
IQ - Iraq 15
BE - Belgio 12
MX - Messico 12
JP - Giappone 11
CZ - Repubblica Ceca 9
ZA - Sudafrica 9
AT - Austria 7
LT - Lituania 5
SA - Arabia Saudita 5
BG - Bulgaria 4
CH - Svizzera 4
IL - Israele 4
TN - Tunisia 4
CO - Colombia 3
IR - Iran 3
MA - Marocco 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BN - Brunei Darussalam 2
CL - Cile 2
EC - Ecuador 2
GR - Grecia 2
HN - Honduras 2
JO - Giordania 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
PK - Pakistan 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AM - Armenia 1
AQ - Antartide 1
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
DZ - Algeria 1
EU - Europa 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MT - Malta 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PA - Panama 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 4.106
Città #
Singapore 228
Ashburn 197
San Jose 148
Chandler 124
Hong Kong 111
Fairfield 106
New York 103
Beijing 77
The Dalles 74
Helsinki 70
Tallinn 67
Seattle 64
Houston 58
Munich 53
Woodbridge 48
Los Angeles 47
Dallas 44
Cambridge 40
Brescia 37
Princeton 37
Warsaw 37
Jacksonville 36
Wilmington 36
Ann Arbor 32
Dublin 32
Milan 32
Lauterbourg 31
Council Bluffs 29
Ho Chi Minh City 29
Istanbul 26
Rome 24
Hangzhou 22
Shanghai 20
Hanoi 19
Dong Ket 16
Redondo Beach 16
San Francisco 15
Buffalo 14
Chicago 14
Des Moines 14
Brooklyn 13
Dearborn 13
Jakarta 13
Montreal 13
Santa Clara 13
London 12
Nuremberg 12
Moscow 11
Orem 11
Toronto 11
Nanjing 10
Belo Horizonte 9
Brussels 9
Turku 9
Badalona 8
Charlotte 8
Frankfurt am Main 8
Shenyang 8
Tokyo 8
Amsterdam 7
Düsseldorf 7
Pune 7
Romola 7
San Diego 7
São Paulo 7
Boardman 6
Boston 6
Falkenstein 6
Kilburn 6
Naples 6
Phoenix 6
Chennai 5
Da Nang 5
Denver 5
Haiphong 5
Johannesburg 5
Lappeenranta 5
Paris 5
Atlanta 4
Baghdad 4
Brno 4
Caxias do Sul 4
Cazzago San Martino 4
Fort Worth 4
Guangzhou 4
Hải Dương 4
Jinan 4
Kampong Loyang 4
Manchester 4
Mazzano 4
Nanchang 4
Olomouc 4
Querétaro 4
Salt Lake City 4
Stockholm 4
Verona 4
Vienna 4
Ankara 3
Arezzo 3
Buenos Aires 3
Totale 2.624
Nome #
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 233
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 223
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 193
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial 178
Female Adnexal Tumor of Probable Wolffian Origin (FATWO): Case Report and Systematic Literature Review 176
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 174
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 174
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 173
A population of TIM4+FOLR2+ macrophages localized in tertiary lymphoid structures correlates to an active immune infiltrate across several cancer types 172
Disseminated Histoplasmosis as AIDS-presentation. Case Report and Comprehensive Review of Current Literature 164
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma 152
Improved Risk Prediction in Human Papillomavirus-Associated Endocervical Adenocarcinoma Through Assessment of Binary Silva Pattern-based Classification: An International Multicenter Retrospective Observational Study Led by the International Society of Gynecological Pathologists (ISGyP) 142
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 142
EXPRESSION PATTERN AND MOLECULAR FUNCTION OF TRASCRIPTION FACTOR FOXM1 (FORKHEAD BOX PROTEIN M1) IN EPITHELIAL OVARIAN CANCER CLINICAL SPECIMENS AND CELL LINES 133
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 133
Real World Application of Chemotherapy Response Score in High Grade Serous Cancer of the Ovary 117
Integrated mutational landscape analysis of uterine leiomyosarcomas 115
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma 113
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 112
Sinonasal cancer encroaching the orbit: Ablation or preservation? 100
Does Reorganization of Clinicopathological Information Improve Prognostic Stratification and Prediction of Chemoradiosensitivity in Sinonasal Carcinomas? A Retrospective Study on 145 Patients 98
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes 97
Primary nasal-ethmoid choriocarcinoma detected by 18F-FDG PET/CT: a rare tumor with complete remission 95
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 95
Parotid pleomorphic and non-pleomorphic adenomas: a mono-institutional series of 512 patients 92
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 87
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 85
Carcinoma Showing Thymus-Like Differentiation (CASTLE) Arising in the Sublingual Gland 85
A retrospective series of long-term survivors of metastatic breast cancer in complete remission 74
Diagnosis, Treatment and Prognosis of Mesonephric Adenocarcinoma of the Vagina: A Literature Review and a Case Report 66
Prevalence of Serous Tubal Intraepithelial Carcinoma (STIC) at the Time of Postpartum Contraceptive Procedures during Caesarean Delivery 59
Oxford Classic-Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions 57
VEGF-D Serum Level as a Potential Predictor of Lymph Node Metastasis and Prognosis in Vulvar Squamous Cell Carcinoma Patients 51
Totale 4.160
Categoria #
all - tutte 21.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.541


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 0 0 0 0 0 0 0 0 0 0 47
2021/2022213 25 24 5 6 10 22 4 11 15 27 16 48
2022/2023313 36 21 15 31 32 67 5 25 49 5 17 10
2023/2024344 18 17 33 28 13 94 21 13 50 9 5 43
2024/2025902 8 22 20 194 67 89 67 42 97 57 114 125
2025/20261.761 167 149 136 220 189 125 273 75 120 154 77 76
Totale 4.160